Clinuvel Pharmaceuticals Ltd (CUV.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,747 | 54,269 | 36,198 | 23,752 | 13,845 |
| Receivables | 6,613 | 4,156 | 5,090 | 3,239 | 4,824 |
| Inventories | 1,288 | 2,136 | 641 | 1,242 | 1,082 |
| TOTAL | $75,156 | $61,153 | $42,269 | $28,470 | $19,974 |
| Non-Current Assets | |||||
| PPE Net | 2,389 | 707 | 169 | 137 | 165 |
| Intangibles | 185 | 185 | 185 | N/A | N/A |
| Other Non-Current Assets | 3,812 | 301 | 282 | 0 | 0 |
| TOTAL | $6,386 | $1,193 | $636 | $137 | $165 |
| Total Assets | $81,542 | $62,345 | $42,905 | $28,607 | $20,138 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,430 | 1,500 | 429 | 579 | 231 |
| TOTAL | $6,660 | $4,960 | $3,471 | $3,148 | $2,288 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 106 | 34 | 18 | -42 | -23 |
| TOTAL | $1,213 | $205 | $18 | $15 | $15 |
| Total Liabilities | $7,873 | $5,166 | $3,489 | $3,163 | $2,304 |
| Shareholders' Equity | |||||
| Common Shares | 151,849 | 151,314 | 148,615 | 148,413 | 146,765 |
| Retained earnings | -80,037 | -95,487 | -112,681 | -125,847 | -133,063 |
| Other shareholders' equity | 1,856 | 1,352 | 3,482 | 2,820 | 4,095 |
| TOTAL | $73,669 | $57,180 | $39,416 | $25,386 | $17,796 |
| Total Liabilities And Equity | $81,542 | $62,345 | $42,905 | $28,549 | $20,100 |